PolyPid Schedules Shareholder Meeting to Approve Significant CEO and Director Option Grants
PYPD sits 63% above its 52-week low of $2.77.
Summary
PolyPid Ltd. announced an upcoming shareholder meeting to vote on significant equity compensation for its CEO and non-executive directors, totaling over $900,000 in options.
Key Events · Corporate Governance and Compliance · PYPD
-
Shareholder Meeting Scheduled
An Annual and Extraordinary General Meeting of Shareholders will be held on July 15, 2026, to vote on several proposals.
-
Significant CEO Option Grant Proposed
Shareholders will vote on granting CEO Dikla Czaczkes Akselbrad up to 149,000 options, vesting over four years, with an exercise price of $4.46 per share. This grant is valued at approximately $664,540.
-
Director Option Grants Proposed
Non-executive directors are proposed to receive annual options valued at $40,000 each, with an amendment to fix the grant terms to an earlier date (May 11, 2026). This results in 9,132 options each at an exercise price of $4.46 per share, totaling approximately $240,000 for six directors.
-
Board Re-election and Auditor Approval
The meeting will also address the re-election of eight board members and the re-appointment of Kost Forer Gabbay & Kasierer as independent auditors.
Analysis · PYPD · Industrial Applications And Services
PolyPid Ltd. is seeking shareholder approval for substantial equity compensation packages for its CEO and non-executive directors. The proposed grants, totaling over $900,000 in value, include 149,000 options for the CEO and annual options valued at $40,000 for each of six non-executive directors. These grants, representing over 1% of the company's market capitalization, are intended to incentivize leadership following recent progress in the D-PLEX₁₀₀ New Drug Application.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PYPD was trading at $4.51 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $86.1M. The 52-week trading range was $2.77 to $5.21. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.